絞り込み

18361

広告

Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.

著者 Zheng J , Cai J , Li H , Zeng K , He L , Fu H , Zhang J , Chen L , Yao J , Zhang Y , Yang Y
Cell Physiol Biochem.2017 Nov 27 ; 44(3):967-981.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (30view , 0users)

Full Text Sources

Medical

Systemic inflammatory response (SIR) is widely considered as a preoperative risk factor for hepatocellular carcinoma (HCC) outcomes. The neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR), two of the prognostic indices, have been investigated in post-therapeutic recurrence and survival of HCC. Here, we quantify the prognostic value of these two biomarkers and evaluate their consistency in different HCC therapies.
PMID: 29179180 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード